Patents by Inventor Baiteng ZHAO

Baiteng ZHAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PTK7 BINDING AGENTS, CONJUGATES THEREOF AND METHODS OF USING THE SAME
    Publication number: 20250115680
    Abstract: The present invention provides PTK7 antibodies, antigen binding portions thereof, other binding agents and PTK7 conjugates thereof, as well as methods and uses of such antibodies and conjugates the treatment of cancer and autoimmune disease.
    Type: Application
    Filed: September 26, 2024
    Publication date: April 10, 2025
    Inventors: Yang XIAO, Lei WANG, Tae HAN, Baiteng ZHAO
  • ANTI-CD70 ANTIBODIES, CONJUGATES THEREOF AND METHODS OF USING THE SAME
    Publication number: 20250066490
    Abstract: The present invention provides CD70 antibodies, antigen binding portions thereof, other binding agents and CD70 conjugates thereof for use in the treatment of cancer and autoimmune disease.
    Type: Application
    Filed: April 22, 2022
    Publication date: February 27, 2025
    Inventors: Baiteng ZHAO, Lei WANG
  • LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME
    Publication number: 20240261427
    Abstract: The present invention provides Polar units, Linker intermediates, Linkers, Drug-Linkers and Conjugates thereof.
    Type: Application
    Filed: March 4, 2024
    Publication date: August 8, 2024
    Inventors: Xiao SHANG, Haidong LIU, Julia GAVRILYUK, Baiteng ZHAO, Tae HAN
  • LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME
    Publication number: 20240245796
    Abstract: The present invention provides Polar units, Linker intermediates, Linkers, Drug-Linkers and Conjugates thereof.
    Type: Application
    Filed: March 4, 2024
    Publication date: July 25, 2024
    Inventors: Xiao SHANG, Haidong LIU, Julia GAVRILYUK, Baiteng ZHAO, Tae HAN
  • LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME
    Publication number: 20240207429
    Abstract: The present invention provides Polar units, Linker intermediates, Linkers, Drug-Linkers and Conjugates thereof.
    Type: Application
    Filed: July 28, 2023
    Publication date: June 27, 2024
    Inventors: Xiao SHANG, Haidong LIU, Julia GAVRILYUK, Baiteng ZHAO, Tae HAN
  • LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME
    Publication number: 20240207418
    Abstract: The present invention provides Polar units, Linker intermediates, Linkers, Drug-Linkers and Conjugates thereof.
    Type: Application
    Filed: July 28, 2023
    Publication date: June 27, 2024
    Inventors: Xiao SHANG, Haidong LIU, Julia GAVRILYUK, Baiteng ZHAO, Tae HAN
  • FOLR1 BINDING AGENTS, CONJUGATES THEREOF AND METHODS OF USING THE SAME
    Publication number: 20240209080
    Abstract: The present invention provides FOLR1 antibodies, antigen binding portions thereof, other binding agents and FOLR1 conjugates thereof for use in the treatment of cancer.
    Type: Application
    Filed: April 8, 2022
    Publication date: June 27, 2024
    Inventor: Baiteng ZHAO
  • HUMANIZED ANTI-LIV1 ANTIBODIES FOR THE TREATMENT OF BREAST CANCER
    Publication number: 20240076402
    Abstract: Methods for using anti-LIV1 antibodies, including drug conjugated anti-LIV1 antibodies, to inhibit proliferation of a LIV-1-expressing cell, as well as for the treatment of one or more diseases or disorders associated with LIV-1-expressing cells (e.g., a LIV-1-associated breast cancer), are provided.
    Type: Application
    Filed: March 7, 2023
    Publication date: March 7, 2024
    Inventors: Dana KENNEDY, Ana KOSTIC, Elizabeth CORWIN, Jonathan DRACHMAN, Peter HAUGHNEY, Baiteng ZHAO, Phillip GARFIN, Maria Corinna PALANCA-WESSELS, Oyewale O. ABIDOYE
  • HUMANIZED ANTI-LIV1 ANTIBODIES FOR THE TREATMENT OF BREAST CANCER
    Publication number: 20200283540
    Abstract: Methods for using anti-LIV1 antibodies, including dmg conjugated anti-LIV1 antibodies, to inhibit proliferation of a LIV-1-expressing cell, as well as for the treatment of one or more diseases or disorders associated with LIV-1-expressing cells (e.g., a LIV-1-associated breast cancer), are provided.
    Type: Application
    Filed: November 30, 2018
    Publication date: September 10, 2020
    Inventors: Dana KENNEDY, Ana KOSTIC, Elizabeth CORWIN, Jonathan DRACHMAN, Peter HAUGHNEY, Baiteng ZHAO, Phillip GARFIN, Corinna PALANCA-WESSELS, Oyewale O. ABIDOYE
  • OPTIMAL DOSING OF A CD19-ANTIBODY DRUG CONJUGATE
    Publication number: 20170182178
    Abstract: Methods of optimal dosing of CD19-antibody drug conjugates are disclosed.
    Type: Application
    Filed: April 7, 2015
    Publication date: June 29, 2017
    Applicant: SEATTLE GENETICS, INC.
    Inventors: Baiteng ZHAO, Tina ALBERTSON, Tae HAN